Physicians in Israel recently reported that six women with autoimmune disorders developed the painful rash known as shingles 3 to 14 days after they received a first or second dose of Pfizer’s COVID-19 vaccine.

Physicians in Israel recently reported that six women with autoimmune disorders developed the painful rash known as shingles 3 to 14 days after they received a first or second dose of Pfizer’s COVID-19 vaccine.
(HealthDay)—COVID-19 “breakthrough” infections, where someone who’s been fully vaccinated becomes infected nonetheless, are exceedingly rare, a new study suggests.
Getting vaccinated may be everyone’s best protection against COVID-19. But giving everyone fair access to vaccines will take more than just providing needles and vials, community health experts say.
India is battling a record-breaking rise in COVID-19 infections that has overwhelmed hospitals and led to severe bed and oxygen shortages.
(HealthDay)—Individuals who have clinically recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and continue to test positive for viral RNA after completing the recommended isolation period do not appear to be infectious to others, according to a study published online April 22 in JAMA Internal Medicine.
In this guide, we’ll show you how to stay within 20m of a player for 3 seconds while wearing a prop disguise as part of Fortnite’s season 6, week 6 challenge.
A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate (NHP) models when given intradermally in abbreviated, low-dose immunization regimen. A similar vaccine candidate was previously shown to be safe and tolerable with a three-dose intramuscular injection …
Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published in PLOS ONE.
The unprecedented development of COVID-19 vaccines less than a year after discovery of this virus was enabled by more than $17 billion of research on vaccine technologies funded by the NIH prior to the pandemic, according to new research from Bentley University’s Center for Integration of Science and Industry. The article, titled “NIH funding for …
As the COVID-19 pandemic has progressed, it has become clear that many survivors—even those who had mild cases—continue to manage a variety of health problems long after the initial infection should have resolved. In what is believed to be the largest comprehensive study of long COVID-19 to date, researchers at Washington University School of Medicine …